These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 29113513)

  • 1. Quantifying HDL proteins by mass spectrometry: how many proteins are there and what are their functions?
    Shao B; Heinecke JW
    Expert Rev Proteomics; 2018 Jan; 15(1):31-40. PubMed ID: 29113513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel reaction monitoring (PRM) and selected reaction monitoring (SRM) exhibit comparable linearity, dynamic range and precision for targeted quantitative HDL proteomics.
    Ronsein GE; Pamir N; von Haller PD; Kim DS; Oda MN; Jarvik GP; Vaisar T; Heinecke JW
    J Proteomics; 2015 Jan; 113():388-99. PubMed ID: 25449833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity.
    Vaisar T; Tang C; Babenko I; Hutchins P; Wimberger J; Suffredini AF; Heinecke JW
    J Lipid Res; 2015 Aug; 56(8):1519-30. PubMed ID: 25995210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to ditch HDL-C as a measure of HDL function?
    Ronsein GE; Heinecke JW
    Curr Opin Lipidol; 2017 Oct; 28(5):414-418. PubMed ID: 28777110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Cluster of Proteins Implicated in Kidney Disease Is Increased in High-Density Lipoprotein Isolated from Hemodialysis Subjects.
    Shao B; de Boer I; Tang C; Mayer PS; Zelnick L; Afkarian M; Heinecke JW; Himmelfarb J
    J Proteome Res; 2015 Jul; 14(7):2792-806. PubMed ID: 26011469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol efflux capacity, macrophage reverse cholesterol transport and cardioprotective HDL.
    Hutchins PM; Heinecke JW
    Curr Opin Lipidol; 2015 Oct; 26(5):388-93. PubMed ID: 26270810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HDL proteome: a marker--and perhaps mediator--of coronary artery disease.
    Heinecke JW
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S167-71. PubMed ID: 19060251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-density lipoprotein: our elusive friend.
    Asztalos BF; Niisuke K; Horvath KV
    Curr Opin Lipidol; 2019 Aug; 30(4):314-319. PubMed ID: 31145119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDL proteome in hemodialysis patients: a quantitative nanoflow liquid chromatography-tandem mass spectrometry approach.
    Mangé A; Goux A; Badiou S; Patrier L; Canaud B; Maudelonde T; Cristol JP; Solassol J
    PLoS One; 2012; 7(3):e34107. PubMed ID: 22470525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding high-density lipoprotein function in disease: recent advances in proteomics unravel the complexity of its composition and biology.
    Birner-Gruenberger R; Schittmayer M; Holzer M; Marsche G
    Prog Lipid Res; 2014 Oct; 56():36-46. PubMed ID: 25107698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDL subclass proteomic analysis and functional implication of protein dynamic change during HDL maturation.
    Zhang Y; Gordon SM; Xi H; Choi S; Paz MA; Sun R; Yang W; Saredy J; Khan M; Remaley AT; Wang JF; Yang X; Wang H
    Redox Biol; 2019 Jun; 24():101222. PubMed ID: 31153037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unravelling HDL-Looking beyond the Cholesterol Surface to the Quality Within.
    Kajani S; Curley S; McGillicuddy FC
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDL and cholesterol: life after the divorce?
    Vickers KC; Remaley AT
    J Lipid Res; 2014 Jan; 55(1):4-12. PubMed ID: 23515282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High density lipoprotein proteome is associated with cardiovascular risk factors and atherosclerosis burden as evaluated by coronary CT angiography.
    Gordon SM; Chung JH; Playford MP; Dey AK; Sviridov D; Seifuddin F; Chen YC; Pirooznia M; Chen MY; Mehta NN; Remaley AT
    Atherosclerosis; 2018 Nov; 278():278-285. PubMed ID: 30347343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Where next with HDL assays?
    Niisuke K; Horvath KV; Asztalos BF
    Curr Opin Lipidol; 2018 Aug; 29(4):293-298. PubMed ID: 29846266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDL Cholesterol Efflux Capacity: Cardiovascular Risk Factor and Potential Therapeutic Target.
    Bhatt A; Rohatgi A
    Curr Atheroscler Rep; 2016 Jan; 18(1):2. PubMed ID: 26710794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deepening our understanding of HDL proteome.
    Ronsein GE; Vaisar T
    Expert Rev Proteomics; 2019 Sep; 16(9):749-760. PubMed ID: 31382838
    [No Abstract]   [Full Text] [Related]  

  • 19. Apolipoprotein A-II is a key regulatory factor of HDL metabolism as appears from studies with transgenic animals and clinical outcomes.
    Maïga SF; Kalopissis AD; Chabert M
    Biochimie; 2014 Jan; 96():56-66. PubMed ID: 24012775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
    Reiner Z
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.